- Report
- September 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- September 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- July 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- July 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- April 2025
- 200 Pages
Global
From €4004EUR$4,490USD£3,472GBP
- Report
- November 2025
- 200 Pages
Global
From €7089EUR$7,950USD£6,147GBP
- Report
- June 2025
- 150 Pages
Global
From €2407EUR$2,699USD£2,087GBP
- Report
- June 2025
- 400 Pages
Global
From €4413EUR$4,949USD£3,827GBP
- Report
- June 2025
- 150 Pages
Global
From €2407EUR$2,699USD£2,087GBP
- Report
- June 2025
- 280 Pages
Global
From €4454EUR$4,995USD£3,862GBP
- Report
- October 2025
- 160 Pages
Global
From €3522EUR$3,950USD£3,054GBP
- Report
- October 2025
- 160 Pages
Global
From €3522EUR$3,950USD£3,054GBP
- Report
- June 2025
- 150 Pages
Global
From €4325EUR$4,850USD£3,750GBP
- Report
- April 2025
- 132 Pages
Global
From €4325EUR$4,850USD£3,750GBP
- Report
- December 2024
- 100 Pages
Global
From €5306EUR$5,950USD£4,601GBP
- Report
- May 2024
- 176 Pages
Global
From €2229EUR$2,500USD£1,933GBP
- Report
- September 2024
- 183 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- February 2024
- 185 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- September 2023
- 88 Pages
Israel
From €3121EUR$3,500USD£2,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4236EUR$4,750USD£3,673GBP

H2 Receptor Antagonists are a type of drug used to treat gastrointestinal disorders. They work by blocking the action of histamine, a chemical that stimulates the production of stomach acid. This helps to reduce the amount of acid in the stomach, which can help to relieve symptoms of acid reflux, heartburn, and other gastrointestinal issues. H2 Receptor Antagonists are available in both prescription and over-the-counter forms. Commonly prescribed H2 Receptor Antagonists include cimetidine, ranitidine, and famotidine.
H2 Receptor Antagonists are widely used to treat a variety of gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. They are also used to prevent and treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
Some companies that produce H2 Receptor Antagonists include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Show Less Read more